Tim Cernak and team duplicated a complex molecule in only three steps.
Image credit: The Cernak Lab
With a big assist from artificial intelligence and a heavy dose of human touch, Tim Cernak’s lab at the University of Michigan made a discovery that dramatically speeds up the time-consuming chemical process of building molecules that will be tomorrow’s medicines, agrichemicals or materials.
The discovery, published in the Feb. 3 issue of Science, is the culmination of years of chemical synthesis and data science research by the Cernak Lab in the College of Pharmacy and Department of Chemistry.
The goal of the research was to identify key reactions in the synthesis of a molecule, ultimately reducing the process to as few steps as possible. In the end, Cernak and his team achieved the synthesis of a complex alkaloid found in nature in just three steps. Previous syntheses took between seven and 26 steps.
“Making a chemical structure that has atoms in just the right place to give you efficacious and nontoxic medicines, for instance, is tricky,” said Cernak, assistant professor of medicinal chemistry and chemistry. “It requires a chemical synthesis strategy grounded in the chemical building blocks you can actually buy and then stitch together using chemical reactions.”
The accomplishment has powerful implications for speeding up the development of medicines.
Cernak compared the construction of these complex molecules to playing chess. You need to orchestrate a series of moves to get to the end of the game. While there’s a near infinite number of possible moves, there’s a logic that can be followed.
“We developed a logic here, based in graph theory, to get to the end as quickly as possible,” he said.
Cernak and colleagues used SYNTHIA Retrosynthesis Software, which provides scientists with a database of pathways, or steps, and formulas for millions of molecular structures. This gave the team an enormous amount of computational synthesis data to play with.
Using an algorithm they developed to curate the data, the researchers identified the steps along the pathway that were high impact, or key steps, and the steps that were making progress toward completing the synthesis but ultimately inefficient for the whole process.
“We hope this research can lead to better medicines,” Cernak said. “So far, we have been limited in the molecular structures we can quickly access with chemical synthesis.”
Original Article: Making molecules faster: U-M discovery dramatically reduces time it takes to build molecules
More from: University of Michigan
The Latest Updates from Bing News
Go deeper with Bing News on:
AI driven chemical synthesis
- Lavita AI Raises $5M Seed Financing to Launch the First Patient-Driven Health Information Marketplace to Accelerate Life Sciences Innovation
Learn more about Lavita AI by downloading the white paper. About Lavita Lavita is the first patient-driven platform for secure sharing of health data. Hosted on Theta Metachain and powered by ...
- Pepper Advantage Acquires Indian AI-driven Credit Management Platform Rieom.ai
a specialist AI/ML-driven credit assessment software platform for the Asian markets Rieom.ai’s first mover advantage in a high potential Indian credit technology market, opens up opportunities ...
- OpenBench and Related Sciences Launch Success-Driven Collaboration
OpenBench, Inc., a pioneer in success-driven small molecule discovery collaborations, today announced the launch of a collaboration with Related Sciences ("RS"), a data science-driven drug discovery ...
- Generative AI: Enterprise Use Cases
Also read: Generative AI Landscape: Current and Future Trends And: 100+ Top Artificial Intelligence Companies 2023 Some enterprises, like marketing and sales-driven companies, have quickly added ...
- Funding for cloud-based generative AI
AI-driven supply chains, AI-driven manufacturing, AI-driven healthcare are all business cases that are on the table. Industries are clamoring for them and for good reason. The value that ...
Go deeper with Bing News on:
- Zuckerberg cash is helping to propel Chicago’s biotech ambitions
While Chicago has seen some big names in finance and corporate America quit, the city has quietly cultivated its biotech sector.
- Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023)
The first poster titled, "Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders," describes the chemical synthesis of Enveric ...
- Mr. Natural: Wyatt Purp Is Rebelling Against Synthetic THC. (So Is the Government.)
These are foreign chemicals that are being put into human bodies.” - Dr. Christopher Hudalla "I feel like they’re corrupting the plant, and I’m connected to it spiritually.” - Wyatt Larew ...
- R&D Spending Surges In GCC’s Chemical Sector
Russia’s February 2022 invasion of Ukraine has reignited international debate about the pace of the global energy transition and the risks ...
- Mechanochemistry makes gold salts that are soluble in organic solvents
A new one-pot mechanochemistry method for processing elemental gold can provide organosoluble gold salts in under one hour. By combining potassium peroxymonosulfate, a common pool cleaner, ...